⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited KingdomNasdaqGS

ROIV

Roivant Sciences Ltd.

Healthcare · Biotechnology

36.49USD

-0.9600 (-2.56%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ROIV.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End03/2026
Last Quarter End06/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 36.49
P/E—
Dvd Ind Yld0.0%
P/B6.23
P/S3,499.4
Curr EV/T12M EBITDA-17.4
Mkt Cap (USD)26.4B
Curr EV (USD)23.3B
2)

Per Share Data

EPS T12M-0.37
DPS—
Bk Val Per Sh5.86
Rev/Sh0.01
Cash/Sh5.32
Curr Shares Out722.3M
FCF/Sh-1.14
3)

Cash Flow Analysis

P/CF-32.3
Curr P/FCF-32.1
CF/NI3.1
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-10840.0%
Eff Interest Rate10.4%
4)

Growth Potential

Dil EPS 1Y Gr-125.0%
Cap 1Y Gr-3.4%
BPS 1Y Gr1.0%
R&D To Sales9704.0%
Retention Rate100.0%
Rev 1Y Gr-71.6%
FCF 1Y Gr10.1%
Assets 1Y Gr5.0%
5)

Profitability

EBITDA-0.6B
EBIT-0.6B
Operating Margin-7914.8%
Pretax Margin-3848.6%
Net Margin-3535.0%
ROA-5.2%
ROE-6.2%
ROC—
Asset Turnover0.00
6)

Structure

Current Ratio16.72
Quick Ratio13.62
Debt/Assets6.1%
Debt/Com Eq7.7%
Net Debt/EBITDA1.56
Tot Debt/Capital7.1%
Gross Margin0.0%
EBIT/Int Exp-15.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.